Vascular Occlusion Device Patent EP4709295A2
Summary
The European Patent Office has published patent application EP4709295A2 for a vascular occlusion device and methods of use, filed by TRANSLATIONAL AND FUNDAMENTAL TECHNOLOGIES INSTITUTE LLC. The patent is designated for several European states and includes classifications related to surgical instruments.
What changed
The European Patent Office (EPO) has published patent application EP4709295A2, titled 'Vascular occlusion device and methods of use thereof.' The application was filed by TRANSLATIONAL AND FUNDAMENTAL TECHNOLOGIES INSTITUTE LLC and lists Bashir Akhavan Tafti as the inventor. The patent is classified under IPC A61B 17/12, which pertains to surgical instruments for occluding vessels, and is designated for numerous European states.
This publication represents the granting of a patent for a specific medical device technology. For companies operating in the medical device sector within the designated European states, this patent signifies potential intellectual property rights that may affect the development, manufacturing, or sale of similar devices. Compliance officers should note this patent publication as part of ongoing landscape monitoring for potential infringement risks or licensing opportunities.
Source document (simplified)
DEVICE FOR VASCULAR OCCLUSION AND METHODS OF USE THEREOF
Publication EP4709295A2 Kind: A2 Mar 18, 2026
Applicants
TRANSLATIONAL AND FUNDAMENTAL
TECHNOLOGIES INSTITUTE LLC
Inventors
TAFTI, Bashir, Akhavan
IPC Classifications
A61B 17/12 20060101AFI20251113BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Diagnosis & Surgery (A61B) publishes new changes.